Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs

Journal of Steroid Biochemistry and Molecular Biology

Volumn 97, Issue 1-2, 2005, Pages 111-120

  Spina, C ^a,b   Tangpricha, V ^a,b   Yao, M ^a,b   Zhou, W ^a,b   Wolfe, M M ^a,b   Maehr, H ^a,b   Uskokovic, M ^a,b   Adorini, L ^a,b   Holick, M F ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Bioxell Inc   (United States)

Author keywords

Colon cancer; Ultraviolet radiation; Vitamin D; Vitamin D analogs

Indexed keywords

1,25 DIHYDROXY 21 (3 HYDROXY 3 TRIFLUOROMETHYL) 4 TRIFLUOROBUTYNYL 19 NOR 20 CHOLECALCIFEROL; 1,25 DIHYDROXY 21 (3 HYDROXY 3 TRIFLUOROMETHYL) 4 TRIFLUOROBUTYNYL 26,27 HEXADEUTERO 19 NOR 20 CHOLECALCIFEROL; BXL 010072; CALCITRIOL; CALCITRIOL DERIVATIVE; CALCIUM; RO 4383561; RO 4383562; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CANCER PREVENTION; CANCER THERAPY; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DIET THERAPY; DOSE RESPONSE; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; SOLAR ENERGY; SPECIES COMPARISON; TUMOR GROWTH; TUMOR VOLUME; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY;

ANIMALS; BINDING SITES; BODY WEIGHT; CALCITRIOL; COLONIC NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR CONFORMATION; SUNLIGHT; TUMOR CELLS, CULTURED; VITAMIN D; VITAMIN D DEFICIENCY;

ANIMALIA; TRIFLUORO;

EID: 27544475448     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.06.003     Document Type: Conference Paper

References (45)

1. R.P. Heaney, K.M. Davies, T.C. Chen, M.F. Holick, and M.J. Barger-Lux Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol Am. J. Clin. Nutr. 77 2003 204 210
2. M.F. Holick Vitamin D: a millennium perspective J. Cell Biochem. 88 2003 296 307
3. 3: a unique photoendocrine system J. Invest. Derm. 77 1 1981 51 58
4. M.F. Holick Sunlight and Vitamin D for bone health and prevention of autoimmune disease, cancers, and cardiovascular disease Am. J. Clin. Nutr. 80 suppl. 2004 1678S 1688S
5. 3 and its photoisomers in human skin Science 216 1982 1001 1003
6. 3 synthesis in human skin J. Clin. Endocrinol. Metab. 67 1988 373 378
7. C. Garland, and F. Garland Do sunlight and Vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9 1980 227 231
8. F. Garland, C. Garland, E. Gorham, and J. Young Jr. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation Prev. Med. 19 1990 614 622
9. W.B. Grant An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates Cancer 94 2002 272 281
10. C.L. Hanchette, and G.G. Schwartz Geographic patterns of prostate cancer mortality Cancer 70 1992 2861 2869
11. C.J. Luscombe, A.A. Fryer, M.E. French, S. Liu, M.F. Saxby, P.W. Jones, and R.C. Strange Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer Lancet 358 2001 641 642
12. E. Lefkowitz, and C. Garland Sunlight, Vitamin D, and ovarian cancer mortality rates in US women Int. J. Epidemiol. 23 1994 1133 1136
13. W.B. Grant, An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation, Cancer 94 (2002) 1867-1875.
14. C.F. Garland, R.B. Shekelle, and E. Barrett-Connor Vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men Lancet 1 1985 307 309
15. M.E. Martinez, E.L. Giovannucci, G.A. Colditz, M.J. Stampfer, D.J. Hunter, F.E. Speizer, A. Wing, and W.C. Willett Calcium, Vitamin D, and the occurrence of colorectal cancer among women J. Natl. Cancer Inst. 88 1996 1375 1382
16. C. Garland, G. Comstock, F. Garland, K. Helsing, E. Shaw, and E. Gorham Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study Lancet 2 1989 1176 1178
17. SEER November 2002 Submission, Rates calculated using SEER*Stat, Population counts for denominators are based on Census 2000 as modified by NCI.
18. 3: in vitro and in vivo effects on human preleukemic and leukemic cells Cancer Treat. Rep. 69 12 1985 1399 1407
19. J.L. Osborn, G.G. Schwartz, D.C. Smith, R. Bahnson, R. Day, and D.L. Trump Phase II trial of 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer Urol. Oncol. 1 5 1995 195 198
20. A.V. Krishnan, D.M. Peehl, and D. Feldman The role of Vitamin D in prostate cancer Recent Results Cancer Res. 164 2003 205 221
21. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid Science 206 4423 1979 1188 1190
22. 3-1α-hydroxylase J. Clin. Endocrinol. Metabol. 86 2 2001 888 894
23. V. Tangpricha, J.N. Flanagan, L.W. Witlatch, C.C. Tseng, T.C. Chen, P.R. Holt, M.S. Lipkin, and M.F. Holick 25-Hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue Lancet 357 2001 1673 1674
24. L. Overbergh, D. Decallonne, A. Calckx, J. Verstuyf, J. Depovere, O. Laureys, R. Rutgeerts, R. Saint-Arnaud, R. Bouillon, and C. Mathieu Identification and immune regulation of the 25-hydroxyvitamin D-1-α-hydroxylase in murine macrophages Clin. Exp. Immunol. 120 2000 139 146
25. 3 Cancer Epidemiol. Biomark. Prev. 7 5 1998 391 395
26. L.W. Whitlatch, M.V. Young, G.G. Schwartz, J.N. Flanagan, K.L. Burnstein, B.L. Lokeshwar, E.S. Rich, M.F. Holick, and T.C. Chen 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer J. Steroid Biochem. 81 2 2002 135 140
27. J.N. Flanagan, L.W. Whitlatch, T.C. Chen, X.H. Zhu, M.T. Holick, X.F. Kong, and M.F. Holick Enhancing 1α-hydroxylase activity with the 25-hydroxyvitamin D-1α-hydroxylase gene in cultured human keratinocytes and mouse skin J. Invest. Dermatol. 115 2001 910 914
28. H.S. Cross, E. Kallay, D. Lechner, W. Gerdenitsch, H. Aldercreutz, and H.J. Armbrecht Phytoestrogens and Vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate and mammary carcinoma J. Nutr. 134 5 2004 1207S 1212S
29. X. Zhao, and D. Feldman Regulation of Vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells Endocrinology 132 4 1993 1808 1814
30. 3 stimulates activator protein-1-dependent Caco-2 cell differentiation J. Biol. Chem. 274 50 1999 35505 35513
31. 3 are differently modified by 9-cis-retinoic acid Cancer Res. 56 3 1996 623 632
32. N. Rochel, M.J. Wurtz, A. Mitschler, B. Klaholz, and D. Margas The crystal structure of the nuclear receptor for Vitamin D bound to its ligand Mol. Cell 5 2000 173 179
33. A. Verstuyf, L. Verlinden, H. Van Baelen, K. Sabbe, C. D'Hallewyn, P. De Clercq, M. Vendewalle, and R. Bouillon The biological activity of nonsteroidal Vitamin D hormone analogs lacking both the C- and D-rings J. Bone Miner. Res. 13 4 1998 549 558
34. H. Maehr, and M.R. Uskokovic Formal desymmetrization of the diastereotopic chains in Gemini calcitriol derivatives with two different side chains at C-20 Eur. J. Org. Chem. 2004 1703 1713
35. C.M. Hansen, and P.H. Mäenpää EB 1089, a novel Vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells Mol. Pharmacol. 54 1997 1173 1179
36. R. Bouillon, W.H. Okamura, and A.W. Norman Structure-function relationships in the Vitamin D endocrine system Endocr. Rev. 16 2 1995 200 257
37. M.R. Uskokovic, P.S. Manchand, S. Peleg, A.W. Norman, Synthesis and preliminary evaluation of the biological properties of a 1α,25- dihydroxyvitamin D3 analog with two side-chains, in: A.W. Norman, R. Bouillon, M. Thomasset (Eds.), Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, Proceedings of the 10th International Vitamin D Workshop, Strasbourg, France, 24 May 1997, University of California, Riverside, CA, 1997, pp. 19-21.
38. S. Väisänen, M. Peräkylä, J.I. Kärkkäinen, M.R. Uskokovic, and C. Carlberg Structural evaluation of the agonistic action of a Vitamin D analog with two side chains binding to the nuclear Vitamin D receptor Mol. Pharmacol. 63 2003 1230 1237
39. H. Maehr, M.R. Uskokovic, Unpublished work.
40. D.P. Griswald, and T.H. Corbett A colon tumor model for anticancer agent evaluation Cancer 36 1975 2441 2444
41. V. Tangricha, C. Spina, M. Yao, T.C. Chen, M.M. Wolfe, M.F. Holick, Vitamin deficiency enhances growth of MC-26 colon cancer xenografts in Balb/C mice, Abstract.
42. M. Yao, E.C. Lam, C.R. Kelly, W. Zhou, and M.M. Wolfe Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer Br. J. Cancer 90 3 2004 712 719
43. T. Takahashi, M. Morotomi, and K. Nomoto A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells Cancer Sci. 95 6 2004 514 519
44. H. Tanaka, E. Abe, C. Miyaura, T. Kuribayashi, K. Konno, and Y. Nishi 1,25-Dihydroxycholeciferol and human myeloid leukemia cell line (HL-60): the presence of cytosol receptor and induction of differentiation Biochem. J. 204 1982 713 719
45. 3 A. Norman Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism 1982 Walter de Gruyter & Co New York 59 64